- Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development. Koller, E., Propp, S., Zhang, H., Zhao, C., Xiao, X., Chang, M., Hirsch, S.A., Shepard, P.J., Koo, S., Murphy, C., Glazer, R.I., Dean, N.M. Cancer Res. (2006)









